Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aim of this study was to characterize the receptor(s) for bombesin (BN) and its homologues (
gastrin
releasing peptide, GRP; neuromedin B,
NMB
; neuromedin C, NMC) in guinea pig gallbladder muscle strips. Dose-dependent contractions were induced by all peptides tested (potency: BN = GRP > NMC >
NMB
, but with similar efficacy: BN = GRP = NMC =
NMB
). The contractions were resistant to tetrodotoxin, atropine, phentolamine, and propranolol. BN tachyphylaxis (1 microM) abolished subsequent contractile responses to BN, GRP and NMC; and partially antagonized the response to
NMB
(66 +/- 7% inhibition).
NMB
tachyphylaxis (10 microM) markedly inhibited subsequent contractile responses to
NMB
(78 +/- 5%); and partially antagonized the contractile response to BN (36 +/- 4%), GRP (31 +/- 12%) and NMC (22 +/- 2%). At 1 microM, both [D-Phe6, Des-Met14]-BN(6-14) ethylamide and ICI 216, 140, two BN receptor antagonists, reduced the contractile actions of BN (82 +/- 4% and 59 +/-8% inhibition, respectively), GRP (75 +/- 11% and 45 +/- 5%), and NMC (73 +/- 9% and 51 +/- 6%) while having no marked effect on
NMB
contractions. Our pharmacological approaches (receptor tachyphylaxis and differential antagonism) provide support for two types of receptors for BN-like peptides on guinea pig gallbladder smooth muscle: a GRP-preferring receptor and a
NMB
-preferring receptor.
...
PMID:Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle. 780 Aug 49
The two bombesin receptor subtypes, neuromedin B (NMB-R) and
gastrin
releasing peptide (GRP-R) receptors, bind their respective ligands with high affinity. To identify molecular components mediating high affinity
NMB
binding, four mutant receptors were constructed, in which different parts of the NMB-R were replaced with the corresponding regions of the GRP-R. When stably expressed in Balb 3T3 fibroblasts, all four NMB-R/GRP-R chimeras were functional and showed
NMB
-induced stimulation of inositol phosphate (IP) formation. Results of 125I-[D-Tyr0]
NMB
displacement assays using unlabeled
NMB
for competition indicated that high affinity
NMB
binding was determined by amino acid sequences in transmembrane domain V (TM-V) of the NMB-R. To identify which amino acid(s) in TM-V of NMB-R contributed to high affinity
NMB
binding, four additional NMB-R mutants were constructed where non-conserved amino acids in TM-V of NMB-R were replaced by the corresponding GRP-R amino acids. Three of the mutations, TyrPheLeu220-222-->PheTyrVal, Ile230-->Val, and His234-->Phe, did not affect high affinity
NMB
binding. The Ile216-->Ser substitution, however, abolished high affinity
NMB
binding and severely impaired the ability of the mutant receptor to stimulate
NMB
-dependent inositol phosphate formation. These results suggest that ILe216 in TM-V of NMB-R may be critical for high affinity
NMB
binding.
...
PMID:The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. 839 57